Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Rating) have been given a consensus rating of “Moderate Buy” by the eight brokerages that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month […]
Day One Biopharmaceuticals (NASDAQ:DAWN – Get Rating) had its price target raised by stock analysts at Piper Sandler from $35.00 to $40.00 in a report released on Monday, The Fly reports. Piper Sandler’s price target would suggest a potential upside of 153.32% from the company’s previous close. Separately, Wedbush upped their price objective on Day […]
May 17 panel assembles to alert the Federal Government of the suffering and deaths of children with brain cancer, a leading killer of children in the USA.
Day One Biopharmaceuticals (NASDAQ:DAWN – Get Rating) issued its quarterly earnings data on Monday. The company reported ($0.36) EPS for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01), MarketWatch Earnings reports. Shares of Day One Biopharmaceuticals stock traded up $0.37 during trading on Wednesday, hitting $12.78. The stock had a trading volume of […]
Strs Ohio Purchases New Position in Day One Biopharmaceuticals, Inc (NASDAQ:DAWN) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.